Reducing Health Systems Costs through a Patient-activation RCT
Reducing Health Systems Costs through a Patient-activation RCT
批准号:
8180686
负责人:
Peter A Muennig
金额:
$24.0万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-16 至 2013-08-31
关键词:
AgeAge-YearsAmericanBehaviorBiological ModelsBreast Cancer Risk FactorCaringCellular PhoneChemistryCollectionComplete Blood CountComputer softwareCost Effectiveness AnalysisDataDeveloped CountriesDiseaseEconomic InflationEconomicsEducationEffectivenessEmployeeEquilibriumExposure toFemaleFundingFutureGenderGrantHealthHealth ExpendituresHealth InsuranceHealth systemHealthcare SystemsHemorrhageHumanInfectionInformation DisseminationInformation ServicesInsuranceInterpersonal RelationsInterventionLow incomeMammographyMeasuresMedicalMedical Care CostsMedical ElectronicsMedicineMonitorNatureOnline SystemsOutcomePatient Self-ReportPatientsPersonal SatisfactionPersonsPhysiciansPopulationPositioning AttributePositive Test ResultPreventionPreventivePreventive InterventionPreventive screeningProceduresProviderQuality-Adjusted Life YearsRadiationRandomizedRandomized Controlled TrialsRecruitment ActivityResearchResourcesRiskRisk FactorsScreening procedureSelf-AdministeredSeriesServicesSiliconSimulateSocial NetworkSurveysSymptomsSystemTechnologyTestingVariantVisitWomanbasebehavior changebilling dataclinical practicecohortcomparative effectivenesscostcost effectivenessdesigndisorder riskfollow-uphealth care deliveryhealth related quality of lifeimprovedindexinginformation gatheringinnovationmarkov modelnovelpost interventionprogramspsychologicpsychological distressresearch studyresponsesimulationsoftware systemstime usetool
中文摘要
描述(由申请人提供):本R21提案是根据RFA-RM-10-015《预防经济学》提交的。我们建议的随机对照试验(RCT)旨在确定知情的患者是否可以说服医生减少不适当的筛查测试的数量,并增加在常规就诊期间安排的适当预防性筛查测试的数量。高达93%的医生自我报告说安排了不必要的检查。总体而言,不必要的测试似乎弊大于利。对患者的伤害可能直接来自测试(例如,感染、出血或暴露在辐射中)或来自假阳性测试结果。假阳性检测结果往往会导致进一步的侵入性检测,从而给患者带来心理上的困扰。不适当的检测还可能造成间接伤害,不必要地增加卫生系统成本,据估计,每年的成本在500亿至6500亿美元之间。医疗成本超过了消费者通胀,成本上涨威胁到了患者保护和平价医疗法案(PPACA)的长期可行性。广泛的研究表明,消息灵通的患者可以影响医生的行为。我们有一个独特的机会,可以随机分配硅谷一家大型科技公司的大约1128名主要是年轻和健康的女性员工,让他们接受3名患者激活干预加上一条健康信息,或者只接收这条信息。患者激活干预需要使用一种创新的教育工具,以告知患者关于他们的年龄、性别和一般疾病风险因素的适当临床实践。它还提供了关于如何与医生沟通适当的测试订购行为的指导。后续行动将通过账单系统和基于网络的自我管理调查进行自动监测,使我们能够以非常低的成本进行随机对照试验。然后,我们将使用这些数据对干预进行成本效益分析。我们还将首次使用随机对照试验数据来探索假阳性乳房X光检查在50岁以下没有乳腺癌危险因素的女性中引发的心理痛苦。患者激活是一种政治中立和创新的方法,可以提高美国预防性医疗服务的提供效率。它有可能优化PPACA内的预防性服务提供。但如果它通过在患者和提供者的社交网络中传播来改变医学文化,它的效果将是最大的。因此,此外,这项研究还将用于试点R01,以跟踪干预通过硅谷一家大型科技公司及其提供商网络中的12,500名员工传播的行为变化。从这些项目中收集的信息--通过全球定位服务以受试者交互跟踪的形式--最终将为基于代理的系统模型提供信息,该模型将审查提高美国医疗保健系统效率的战略。
公共卫生相关性:我们建议对一种新的干预措施进行随机对照试验,以通过患者激活干预减少不适当的预防性测试(并增加适当的测试)。这笔赠款为根据《患者保护和平价医疗法案》改善预防性医疗和降低医疗系统成本开辟了一条道路,与之前的提案相比,该法案在政治上的争议性较小,因为该机构是放在患者身上的,而不是从提供者那里剔除的。
英文摘要
DESCRIPTION (provided by applicant): This R21 proposal is submitted in response to RFA-RM-10-015 the Economics of Prevention. Our proposed randomized controlled trial (RCT) is designed to determine whether well-informed patients can persuade doctors to reduce the number of inappropriate screening tests and increase the number of appropriate preventive screening tests that are ordered during routine medical visits. Up to 93% of doctors self-report ordering unnecessary tests. Unnecessary tests are those that, on balance, appear to produce more harm than good. Harm to the patient can arise directly from the test (e.g., infection, bleeding, or exposure to radiation) or from false positive test results. False positive test results often produce psychological distress for the patient by leading to further invasive testing. Inappropriate testing can also cause indirect harm by needlessly increasing health system costs, and has been estimated to cost between $50 billion and $650 billion annually. Medical care costs outstrip consumer inflation, and cost increases threaten the long-term viability of the Patient Protection and Affordable Care Act (PPACA). A wide range of studies has shown that well-informed patients can influence physician behavior. We have the unique opportunity to randomly assign approximately 1,128 predominately young and healthy female employees at a large Silicon Valley technology firm to either receive a 3patient activation intervention plus a health message or to receive the message alone. The patient activation intervention entails the use of an innovative education tool to inform patients regarding the appropriate clinical practice for their age, gender, and general risk factors for disease. It also provides guidance on how to communicate appropriate test ordering behavior with their physician. Follow-up will be monitored automatically via billing systems and web-based self-administered surveys, allowing us to conduct an RCT at very low cost. We will then use these data to conduct a cost- effectiveness analysis of the intervention. We will also, for the first time, use RCT data to explore psychological distress induced by false positive mammograms among women under 50 years of age who have no risk factors for breast cancer. Patient activation is a politically neutral and innovative means of increasing the efficiency of preventive healthcare delivery in the U.S. It has the potential to optimize preventive service delivery within PPACA. But its effectiveness will be greatest if it changes the culture of medicine by spreading within patient and provider social networks. Therefore, in addition, this study will also serve to pilot an R01 to track behavior change as an intervention spreads through the 12,500 employees within the social network of a large Silicon Valley technology firm and their provider networks. Information gathered from these programs-in the form of subject interaction tracking via Global Positioning Service-will eventually inform an agent-based systems model examining strategies for improving the efficiency of the US health care system.
PUBLIC HEALTH RELEVANCE: We propose a randomized controlled trial of a novel intervention to reduce inappropriate preventive testing (and increase appropriate testing) through a patient activation intervention. This grant forwards a path to improving preventive care and reducing health system costs under the Patient Protection and Affordable Care Act that is less politically contentious than previous proposals, as agency is placed on the patient rather than removed from the provider.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Project STAR Healthy Aging Experiment
-
批准号:10653369
-
项目类别:
-
资助金额:$20.56万
-
财政年份:2023
-
负责人:Peter A Muennig
-
依托单位:
An Expanded Dataset to Study Psychosocial Influences on Health Disparities
-
批准号:8820399
-
项目类别:
-
资助金额:$21.47万
-
财政年份:2014
-
负责人:Peter A Muennig
-
依托单位:
An Expanded Dataset to Study Psychosocial Influences on Health Disparities
-
批准号:8982248
-
项目类别:
-
资助金额:$23.76万
-
财政年份:2014
-
负责人:Peter A Muennig
-
依托单位:
Reducing Health Systems Costs through a Patient-activation RCT
-
批准号:8332652
-
项目类别:
-
资助金额:$18.16万
-
财政年份:2011
-
负责人:Peter A Muennig
-
依托单位:
A dataset for the study of the social determinants of health.
-
批准号:7852814
-
项目类别:
-
资助金额:$79.36万
-
财政年份:2009
-
负责人:Peter A Muennig
-
依托单位:
A dataset for the study of the social determinants of health.
-
批准号:7941923
-
项目类别:
-
资助金额:$39.08万
-
财政年份:2009
-
负责人:Peter A Muennig
-
依托单位:
海外基金